Amyloid TTR Treatment Studies

episode

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Inherited Mindset: Firing Your Family’s Financial Beliefs 3 min · 27 Sep 2026 · The Level Up Podcast w/ Paul Alex

The Rise of the AI Moderates 32 min · 27 Sep 2026 · The AI Daily Brief: Artificial Intelligence News and Analysis

NPR News: 09-27-2026 7AM EDT 5 min · 27 Sep 2026 · NPR News Now

7AM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

The Sunday Paper Review 27th September 31 min · 27 Sep 2026 · The Pat Kenny Show

Danielle with… Amber Glenn and Pasha Pashkov 1h 0m · 27 Sep 2026 · Pod Meets World

Report any issue

Source

Recorded23 Jul 2018

Publisheranchor.fm ↗

Handlerec:820506

Show notes

Dr. Ted Burns interviews Dr. William Litchy and Drs. Jim and Peter Dyck on their articles, Amyloid TTR treatment studies. The articles are Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis (N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793) and Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis (N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153.)

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in